Nitric oxide inhibits the accumulation of CD4+CD44hiTbet+CD69lo T cells in mycobacterial infection

European Journal of Immunology

Volumn 42, Issue 12, 2012, Pages 3267-3279

  Pearl, John E ^a   Torrado, Egidio ^a   Tighe, Michael ^a   Fountain, Jeffrey J ^a   Solache, Alejandra ^a,b   Strutt, Tara ^d   Swain, Susan ^d   Appelberg, Rui ^c   Cooper, Andrea M ^a  

^a TRUDEAU INSTITUTE   (United States)

^b University of Porto ^*

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Bacterial infection; CD4+ T cells; Cell differentiation; Immunopathology; Inflammation

Indexed keywords

ALPHA4 INTEGRIN; BETA1 INTEGRIN; CD4 ANTIGEN; HERMES ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTEGRIN; NITRIC OXIDE; TRANSCRIPTION FACTOR T BET; VERY LATE ACTIVATION ANTIGEN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATYPICAL MYCOBACTERIOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; EFFECTOR CELL; ENZYME ACTIVITY; INHIBITION KINETICS; LYMPHOCYTE SUBPOPULATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TRANSCRIPTOMICS;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; GRANULOMA, RESPIRATORY TRACT; LECTINS, C-TYPE; MICE; MICE, KNOCKOUT; MYCOBACTERIUM AVIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; T-BOX DOMAIN PROTEINS; TH1 CELLS; TUBERCULOSIS, PULMONARY;

EID: 84871273202     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201142158     Document Type: Article

References (55)

1. Cooper, A. M., Cell mediated immune responses in tuberculosis. Annu. Rev. Immunol. 2009. 27: 393-422.
2. Nathan, C., Inducible nitric oxide synthase: what difference does it make? J. Clin. Invest. 1997. 100: 2417-2423.
3. Bogdan, C., Nitric oxide and the immune response. Nat. Immunol. 2001. 2: 907-916.
4. Cooper, A. M., Adams, L. B., Dalton, D. K., Appelberg, R.andEhlers, S., IFN-γ and NO in mycobacterial disease: new jobs for old hands. Trends Microbiol. 2002. 10: 221-226.
5. Niedbala, W., Cai, B.andLiew, F. Y., Role of nitric oxide in the regulation of T-cell functions. Ann. Rheum. Dis. 2006. 65: iii37-iii40.
6. Gomes, M. S., Florido, M., Pais, T. F. and Appelberg, R., Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene. J. Immunol. 1999. 162: 6734-6739.
7. Hirst, D. and Robson, T., Nitric oxide and physiology. In McCarthy, H. O. and Coulter, J. A. (Eds.), Methods in Molecular Biology Springer, London, 2011, pp. 1-13.
8. Xu, W., Charles, I. G. andMoncada, S., Nitric oxide: orchestrating hypoxia regulation through mitochondrial respiration and the endoplasmic reticulum stress response. Cell. Res. 2005. 15: 63-65.
9. Hirst, D. and Robson, T., Nitrosative stress in cancer therapy. Front. Biosci. 2007. 12: 3406-3418.
10. Brown, G., Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biocim. Biophys. Acta - Bioenerg. 2001. 1504: 46-57.
11. 2-induced endothelial barrier dysfunction: mechanisms of protection. Am. J. Physiol. - Lung Cell. Mol. Physiol. 2001. 280: L116-L126.
12. Szabo, C., Ischiropoulos, H. and Radi, R., Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 2007. 6: 662-680.
13. Bogdan, C., Regulation of lymphocytes by nitric oxide. Methods Mol. Biol. 2011. 677: 375-393.
14. Fischer, T. A., Palmetshofer, A., Gambaryan, S., Butt, E., Jassoy, C., Walter, U., Sopper, S.et al., Activation of cGMP-dependent protein kinase Iβ inhibits interleukin 2 release and proliferation of T-cell receptor-stimulated human peripheral T cells. J. Biol. Chem. 2001. 276: 5967-5974.
15. Millar, A. E., Sternberg, J., McSharry, C., Wei, X.-Q., Liew, F. Y. and Turner, C. M. R., T-cell responses during Trypanosoma brucei infections in mice deficient in inducible nitric oxide synthase. Infect. Immun. 1999. 67: 3334-3338.
16. Albina, J., Abate, J. and Henry, W., Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T-cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway. J. Immunol. 1991. 147: 144-148.
17. Gregory, S., Wing, E., Hoffman, R. and Simmons, R., Reactive nitrogen intermediates suppress the primary immunologic response to Listeria. J. Immunol. 1993. 150: 2901-2909.
18. Laroux, F., Lefer, D., Kawachi, S., Scalia, R., Cockrell, A., Gray, L., Van der Heyde, H. et al., Role of nitric oxide in the regulation of acute and chronic inflammation. Antioxid. Redox Signal. 2000. 2: 391-396.
19. Niedbala, W., Cai, B., Liu, H., Pitman, N., Chang, L. and Liew, F. Y., Nitric oxide induces CD4+CD25 +Foxp3- regulatory T cells from CD4+CD25- T cells via p53, IL-2, and OX40. Proc. Natl. Acad. Sci. USA 2007. 104: 15478-15483.
20. Niedbala, W., Alves-Filho, J. C., Fukada, S. Y., Vieira, S. M., Mitani, A., Sonego, F., Mirchandani, A.et al, Regulation of type 17 helper T-cell function by nitric oxide during inflammation. Proc. Natl. Acad. Sci. USA 2011. 108: 9220-9225.
21. Diefenbach, A., Schindler, H., Röllinghoff, M., Yokoyama, W. and Bogdan, C., Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science 1999. 284: 951-955.
22. Huang, F.-P., Niedbala, W., Wei, X.-Q., Xu, D., Feng, G.-j., Robinson, J. H., Lam, C. et al., Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur. J. Immunol. 1998. 28: 4062-4070.
23. Niedbala, W., Wei, X.-Q., Campbell, C., Thomson, D., Komai-Koma, M. and Liew, F. Y., Nitric oxide preferentially induces type 1 T-cell differentiation by selectively up-regulating IL-12 receptor β2 expression via cGMP. Proc. Natl. Acad. Sci. USA 2002. 99: 16186-16191.
24. Niedbala, W., Wei, X.-Q., Piedrafita, D., Xu, D. and Liew, F. Y., Effects of nitric oxide on the induction and differentiation of Th1 cells. Eur. J. Immunol. 1999. 29: 2498-2505.
25. Lee, S.-W., Choi, H., Eun, S.-Y., Fukuyama, S. and Croft, M., Nitric oxide modulates TGF-β-directive signals to suppress Foxp3+ regulatory T-cell differentiation and potentiate Th1 development. J. Immunol. 2011. 186: 6972-6980.
26. Dalton, D. K., Haynes, L., Chu, C. Q., Swain, S. L. and Wittmer, S., Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J. Exp. Med. 2000. 192: 117-122.
27. Nabeshima, S., Nomoto, M., Matsuzaki, G., Kishihara, K., Taniguchi, H., Yoshida, S. and Nomoto, K., T-cell hyporesponsiveness induced by activated macrophages through nitric oxide production in mice infected with Mycobacterium tuberculosis. Infect. Immun. 1999. 67: 3221-3226.
28. MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J., Shah, S. K. and Nathan, C. F., Identification of NOS2 as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 1997. 94: 5243-5248.
29. Lousada, S., Flórido, M. and Appelberg, R., Regulation of granuloma fibrosis by nitric oxide during Mycobacterium avium experimental infection. Int. J. Exp. Pathol. 2006. 87: 307-315.
30. Ehlers, S., Kutsch, S., Benini, J., Cooper, A. M., Hahn, C., Gerdes, J., Orme, I. M. et al., NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium infected mice without affecting bacterial loads. Immunology 1999. 98: 313-323.
31. Reiley, W. W., Shafiani, S., Wittmer, S. T., Tucker-Heard, G., Moon, J. J., Jenkins, M. K., Urdahl, K. B. et al., Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 2010. 107: 19408-19413.
32. Florido, M., Cooper, A. M. and Appelberg, R., Immunological basis of the development of necrotic lesions following Mycobacterium avium infection. Immunology 2002. 106: 590-601.
33. Bedard, K. and Krause, K.-H., The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007. 87: 245-313.
34. Florido, M., Pearl, J., Solache, A., Borges, M., Haynes, L., Cooper, A. and Appelberg, R., Gamma interferon-induced T-cell loss in virulent Mycobacterium avium infection. Infect. Immun. 2005. 73: 3577-3586.
35. Testi, R., Phillips, J. H. and Lanier, L. L., Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. J. Immunol. 1989. 142: 1854-1860.
36. Corbett, J., Tilton, R., Chang, K., Hasan, K., Ido, Y., Wang, J., Sweetland, M. et al., Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 1992. 41: 552-556.
37. Ehlers, S., Benini, J., Held, H.-D., Roeck, C., Alber, G. and Uhlig, S., αβ T-cell receptor-positive cells and interferon-γ, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology. J. Exp. Med. 2001. 194: 1847-1859.
38. Florido, M., Goncalves, A.-S., Silva, R. A., Ehlers, S., Cooper, A. M. and Appelberg, R., Resistance of virulent Mycobacterium avium to gamma interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis. Infect. Immun. 1999. 67: 3610-3618.
39. Mayer, K., Mohrs, K., Crowe, S., Johnson, L., Rhyne, P., Woodland, D. and Mohrs, M., The functional heterogeneity of type I effector T cells in response to infection is related to the potential for IFN-γ production. J. Immunol. 2005. 180: 7732-7739.
40. Li, X., McKinstry, K., Swain, S. and Dalton, D., IFN-gamma acts directly on activated CD4+ T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals. J. Immunol. 2007. 179: 939-949.
41. Feng, C., Zheng, L., Jankovic, D., Báfica, A., Cannons, J., Watford, W., Chaussabel, D. et al., The immunity-related GTPase Irgm1 promotes the expansion of activated CD4+ T-cell populations by preventing interferon-gamma-induced cell death. Nat. Immunol. 2008. 9: 1279-1287.
42. Paoluzzi, L. and O'Connor, O., Targeting survival pathways in lymphoma. Adv. Exp. Med. Biol. 2010. 687: 79-96.
43. Sasaki, K., Pardee, A. D., Okada, H. and Storkus, W. J., IL-4 inhibits VLA-4 expression on Tc1 cells resulting in poor tumor infiltration and reduced therapy benefit. Eur. J. Immunol. 2008. 38: 2865-2873.
44. Sasaki, K., Pardee, A., Qu, Y., Zhao, X., Ueda, R., Kohanbash, G., Bailey, L. et al., IL-4 suppresses very late antigen-4 expression which is required for therapeutic Th1 T-cell trafficking into tumors. J. Immunother. 2009. 32: 793-802.
45. Calderon, B., Carrero, J. A., Miller, M. J. and Unanue, E. R., Entry of diabetogenic T cells into islets induces changes that lead to amplification of the cellular response. Proc. Natl. Acad. Sci. USA 2011. 108: 1567-1572.
46. Suvas, S., Kim, B. and Rouse, B. T., Homeostatic expansion of CD4+ T cells upregulates VLA-4 and exacerbates HSV-induced corneal immunopathology. Microbes Infect. 2008. 10: 1192-1200.
47. Nguyen, K., Sylvain, N. R. and Bunnell, S. C., T-cell costimulation via the integrin VLA-4 inhibits the actin-dependent centralization of signaling microclusters containing the adaptor SLP-76. Immunity 2008. 28: 810-821.
48. Orme, I. and Roberts, A., Animal models of mycobacteria infection (section 19.5.1). Curr. Protoc. Immunol. 2001. 30:19.5.1-19.5.22.
49. Roberts, A., Cooper, A., Belisle, J., Turner, J., Gonzalez-Juarerro, M. and Orme, I., Murine models of tuberculosis. In Kaufmann, S. and Kabelitz, D. (Eds.), Methods in Microbiology, Second Edn. Academic Press, London, 2002, pp. 433-462.
50. Khader, S., Pearl, J., Sakamoto, K., Gilmartin, L., Bell, G., Jelley-Gibbs, D., Ghilardi, N. et al., IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γ responses if IL-12p70 is available. J. Immunol. 2005. 175: 788-795.
51. Simon, R., Lam, A., Li, M., Ngan, M., Menenzes, S. and Zhao, Y., Analysis of gene expression data using BRB-ArrayTools. Cancer Inform. 2007. 3: 11-17.
52. Simon, R., Korn, E., McShane, L., Radmacher, M., Wright, G. and Zhao, Y., Design and analysis of DNA microarray investigations. Springer Verlag, New York, 2003.
53. Simon, R. and Lam, A., BRB array tools users technical reports. Biometric Research Branch, National Cancer Institute, Bethesda, MD, 2006.
54. Wu, Z., Itrizarry, R., Gentleman, R., Murillo, F. and Spencer, F., A model based background adjustment for oligonucleotide expression arrays. J. Am. Stat. Assoc. 2004. 99: 909-917.
55. Seo, J.and Hoffman, E., Probe set algorithms: is there a rational best bet? BMC Bioinform. 2006. 7: 395.